| Factor Information | |
|---|---|
| Data ID | 2372 |
| Factor | Correlation between exercise time and neonatal events |
| Description | Exercise time, peak HR, and V˙O2 at the anaerobic threshold and that at peak exercise were associated with neonatal events. |
| Biomarker | YES |
| Classification | Z (combined factor - combined factor) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | impact on neonatal events |
| p Value | 0.0196 |
| OR | 0.48 |
| Conclusion | Exercise time, peak HR, and V˙O2 at the anaerobic threshold and that at peak exercise were associated with neonatal events. CPX parameters predict pregnancy outcome and peak HR >150 beats/min and/or peak V˙O2 >25 ml · kg–1 · min–1 may be reference value(s) for a safer pregnancy outcome in WCHD. |
| Risk Factor | protective factor |
| CHD Type | |
|---|---|
| ID | 600 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
| Reference | |
|---|---|
| PMID | 23059769 |
| Year | 2013 |
| Title | Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | Pregnant woman | |
| Source | N/A | |
| Region | Suita, Japan | |
| Method | cardiopulmonary exercise testing (CPX) | |
| Race | Asia | |
| Disease History | N/A | |
| Treatment History | Medications: Diuretics, Anti-coagulant, Angiotensin converting enzyme inhibitor, Anti-arrhythmic, Digoxin | |
| Group | WCHD with neonatal events(Treatment) | WCHD without neonatal events(Control) |
| Number | N/A | N/A |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
